Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Green Cap Health vs Rebody Health

Green Cap Health
Graded #258

Lower grade

vs+4.5
Rebody Health
Graded #159

Higher grade

The verdict

Rebody Health takes it — 67.7/100 to 63.2/100.

Rebody Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Rebody Health (rebodyhealth.com), operated by Compound Technologies Inc., is a transparent-pricing GLP-1 and wellness telehealth service that publishes prices up front.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGreen Cap Health +28
74
46
Dose & formulationRebody Health +24
64
88
Clinical oversightRebody Health +13
68
81
Labs & monitoringRebody Health +1
52
53
FulfillmentRebody Health +28
56
84
Contract termsRebody Health +8
47
55
Green Cap Health · left barRebody Health · right bar

The numbers

MetricGreen Cap HealthRebody Health
WeighScore63.2/10067.7/100
GradeCC
Scorecard rank#258#159
Semaglutide$129/mo (6-month plan, compounded)$200/mo (starting dose, compounded)
Tirzepatide$199/mo (6-month plan, compounded)$250/mo (starting dose, compounded)
Coverage1 state47 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Green Cap Health

Graded #258 · C

Strengths

  • Vertically integrated: the prescribing practice and the compounding pharmacy are the same company, so the supply chain is short and named
  • Same-day provider review and 1-3 day discreet shipping
  • The full commitment ladder is published, so the month-to-month rate and the six-month rate can be compared directly

Where it loses points

  • The advertised $2.63-a-day and $79 first-month figures do not correspond to any purchasable plan; the cheapest real rates are $129/mo semaglutide and $199/mo tirzepatide, both on six-month commitments, and month-to-month is $179 and $279
  • The terms disclose a separate Weight Management Program Membership Fee, charged periodically on top of the plan and revealed only during checkout — it appears on no product page
  • The terms also state recurring fees are charged in advance without seeking any additional authorisation
  • Service is Texas-only, so nothing here is available to a reader outside that state
  • The site's terms link out to lifemd.com's terms — the legal text is another company's
Rebody Health

Graded #159 · C

Strengths

  • Publishes transparent, dose-based pricing up front on a public pricing page, so you can see costs without signing up
  • Offers compounded semaglutide and tirzepatide as both weekly injections and daily oral 'melt' tablets
  • Also carries brand-name Wegovy and Zepbound for patients who want FDA-approved products
  • Clear plan-term vs dose-tier structure; the refill price is shown before each shipment, plus $50 off the first month
  • Names its operating company (Compound Technologies Inc.) and references LegitScript approval

Where it loses points

  • Individual compounding pharmacies are not named on the marketing site
  • Not available in Massachusetts, Rhode Island, or Vermont
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
  • Dose-scaled pricing means the monthly cost can rise as your prescribed dose increases

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard